SUBLIMEDZ2.E19In 2018, SUBLIMED launched its portable and miniaturised neurostimulator, actiTENS. A true breakthrough for patients who do not have many alternatives other than medication and especially opioids, which were responsible in 2020 of more than 80,000 deaths only in the United States.actiTENS is a compact and connected neurostimulator based on transcutaneous electrical neurostimulation therapy. actiTENS directly targets patients’ pain through two mechanisms, the first actively interfering with pain signals’ neural transmission, and the second stimulating the production of endorphins, for long-lasting pain relief effects. The device can be controlled directly from a smartphone, be used unnoticeably and accompanies patients in their daily activities. Its small size, light weight and flexible architecture enable easy placement on different parts of the body, in accordance with patients’ needs and doctors’ recommendations. actiTENS has now more than 15,000 active users in France and is beginning its international expansion to provide chronic pain patients around the world with a clinically validated drug-free treatment.Come and see Sublimed at the Za'abeel 2 French pavilion (Booth Z2E19) and find all about this drug-free medical device for chronic pain management.